Clinical Trials Insight: 700023973

Trial Profile

Clinical Trials Insight: 700023973

Phase of Trial: Phase I

Latest Information Update: 28 Feb 2008

At a glance

  • Drugs Alvespimycin; Trastuzumab
  • Indications Solid tumours
  • Focus Adverse reactions
  • Sponsors Kosan Biosciences
  • Most Recent Events

    • 28 Feb 2008 Kosan has reported that this trial will be discontinued.
    • 10 Sep 2007 Interim results in 23 patients with HER2-positive breast cancer and 3 patients with ovarian cancer were presented at the ASCO Breast Cancer Symposium in September 2007 (9079856).
    • 20 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top